CTech 24/7
- Intel’s Israeli workforce hits decade low as more layoffs loom
- As Israeli tech ecosystem matures, the meaning of exit evolves
- "It’s important to plan the vision from the very beginning"
- “Selling the product is the easy part. Convincing people to believe in you is the hard part”
More stories in CTechImmunotherapy
9 stories about Immunotherapy
Cancer Immunotherapy Startup NeoTX Raises $45 Million
Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
CEO of Nasdaq-Listed Cell Immunotherapy Company Enlivex Steps Down
Compugen Falls 17% on Employee Cuts Announcement
Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen
AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen
03.04.18The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen
Kite Pharma’s Cancer Drug Gets Regulatory Nod
Kite Pharma Sale Triggers Scientist Quarrel
Cell Immunotherapy Company Raises $8 Million
